PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Подборка полезной литературы – часть 2

Опубликовано 29 июня, 201930 июня, 2019 frozencat

An Introduction to Categorical Data Analysis

Categorical Data Analysis

Clinical Trials, Second Edition: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines

Randomization in clinical trials : theory and practice

Introduction to Statistical Methods for Clinical Trials

Introduction to Randomized Controlled Clinical Trials, Second Edition (Texts in Statistical Science Series)

Statistical Advances in the Biomedical Sciences: Clinical Trials, Epidemiology, Survival Analysis, and Bioinformatics (Wiley Series in Probability and Statistics)

Clinical Trials: A Practical Guide to Design, Analysis, and Reporting

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook and Computer Simulations

Basic Pharmacokinetics

Basic Pharmacokinetic Concepts and Some Clinical Applications

Using R and RStudio for Data Management, Statistical Analysis and Graphics

A Data Scientist’s Guide to Acquiring, Cleaning, and Managing Data in R

DAMA-DMBOK (2nd Edition): Data Management Body of Knowledge

 

Рубрики: Блог, Общее

Навигация по записям

Предыдущая запись: Протокол и отчет клинического исследования биоэквивалентности: шаблон
Следующая запись: ClinicalTrialUtilities: обзор

Свежие записи

  • Оценка данных вариации литературных источников для определения объема выборки клинических исследований биоэквивалентности
  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4

Галерея

20180816 193539
20180131 184310
20170802 201119
20170730 175202
20180129 140230
20180814 153419
  • Check Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-29 By FDA
  • Procedural advice for veterinary vaccine antigen master file (VAMF) certification
    Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-11-28
  • FluMist
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-11-28 By FDA
  • Procedural advice for vaccine platform technology master file (vPTMF) certification
    Source: EMA - Scientific guidelines (human and veterinary) Published on 2025-11-28
  • Guidance for stepwise PIPs (sPIPs)
    Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-11-28
  • QE3 Guideline for Extractables and Leachables: Supporting Documentation: Class 3 Leachable Monographs
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-28 By FDA
  • Q3E Guideline for Extractables and Leachables
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-28 By FDA
  • Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 57, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-28
  • Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 60, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-28
  • Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 24, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-28
  • Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Date of authorisation: 19/11/2015, Revision: 21, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-28
  • Newly Added Guidance Documents
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-28 By FDA
  • Current Good Manufacturing Practice for Medical Gases
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-28 By FDA
  • Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 1, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-28
  • PDUFA VIII: Fiscal Years 2028 – 2032
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-28 By FDA
Older posts
Тема: Scaffold от Danny Cooper.